CERG-03 EPIDEMIOLOGY AND MANAGEMENT OF BRAIN TUMORS IN ADULT IN BENIN : A RETROSPECTIVE COHORT STUDY.

Le résumé fourni par la source

Abstract Brain tumor patients face numerous challenges, including the necessity of surgery, adjuvant therapy, financial constraints, and spiritual needs. In Benin, the healthcare journey for these patients appears fraught with uncertainty, and the burden of brain tumors remains unquantified. A patient-centered care strategy must be implemented to effectively address the unique needs of brain tumor patients, different from those of infectious disease treatment. The aim of this study was to understand the barriers to brain tumor management through a baseline survey and to increase awareness of brain tumors among healthcare workers and the public in Benin. Methods A retrospective review was conducted on brain tumor patients at the neurosurgery department of Hubert Maga University Hospital in Cotonou from 2014 to 2023. Results In the past decade, 160 brain tumor patients have been treated, with 55 cases since the initiation of the brain tumor program in 2022 (figure 1). Males were more prevalent (57%), with a mean age of 46 years, and the most affected age group was 40-60 years (55%) (table 1). Common symptoms included headaches (58%), visual field impairments (45%), and seizures (33%). Meningioma (40%), pituitary adenoma (28%), and glioma (15%) were the most frequently identified tumors (figure 2). A significant percentage of patients (60%) underwent surgery, with the quality of resection playing a crucial role in overall survival rates. Conclusion This study underscores the persistent reluctance toward brain surgery among patients, with many harboring fears regarding the procedure. Since the inception of the brain tumor program in 2022, data collection has exceeded that of the previous 8 years. Enhanced knowledge regarding the epidemiology of brain tumors is crucial to augmenting awareness in Benin.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.